MEDIHALER ERGOTAMINE Drug Patent Profile
✉ Email this page to a colleague
When do Medihaler Ergotamine patents expire, and what generic alternatives are available?
Medihaler Ergotamine is a drug marketed by 3M and is included in one NDA.
The generic ingredient in MEDIHALER ERGOTAMINE is ergotamine tartrate. There are thirteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ergotamine tartrate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MEDIHALER ERGOTAMINE?
- What are the global sales for MEDIHALER ERGOTAMINE?
- What is Average Wholesale Price for MEDIHALER ERGOTAMINE?
Summary for MEDIHALER ERGOTAMINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 21 |
| Patent Applications: | 5 |
| DailyMed Link: | MEDIHALER ERGOTAMINE at DailyMed |
US Patents and Regulatory Information for MEDIHALER ERGOTAMINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3m | MEDIHALER ERGOTAMINE | ergotamine tartrate | AEROSOL, METERED;INHALATION | 012102-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
